Strength
8 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332017630
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
FESOTERODINE FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA204973On Market Since
1/6/2023
Related Drugs
Same classification
No related drugs found.